Skip to main content

PHIO

Stock
Health Care
Biotechnology

Performance overview

PHIO Price
Price Chart

Forward-looking statistics

Beta
1.01
Risk
100.00%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.

Company info

SectorHealth Care
IndustryBiotechnology
Employees9
Market cap$3.4M

Fundamentals

Enterprise value-$2.0M
Revenue$0.0
Revenue per employee—
Profit margin0.00%
Debt to equity0.00

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)-$9.02
Dividend per share—
Revenue per share$0.00
Avg trading volume (30 day)$1M
Avg trading volume (10 day)$599K
Put-call ratio—

Macro factor sensitivity

Growth+12.7
Credit-2.6
Liquidity-9.5
Inflation+12.1
Commodities+2.0
Interest Rates+0.1

Valuation

Dividend yield0.00%
PEG Ratio0.07
Price to sales—
P/E Ratio0.07
Enterprise Value to Revenue—
Price to book0.94

Upcoming events

Next earnings dayApril 1, 2025
Next dividend day—
Ex. dividend day—

News

New Strong Buy Stocks for May 28th

PHIO, FLNG, BWB, ALRS and HALO have been added to the Zacks Rank #1 (Strong Buy) List on May 28, 2025.

Zacks Investment Research (May 28, 2025)
Cancer-Focused Phio Pharmaceuticals Stock Gains 300% On Monday - Here's Why

On Monday, Phio Pharmaceuticals Corp. PHIO stock skyrocketed with a strong session volume of 201.04 million, compared to the average volume of 362.72k, according to data from Benzinga Pro.

Benzinga (January 13, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free